Webinar | How Will Microbiome Reshape Anti-Aging Skin Care in 2026 Register Here

Nido Biosciences

Nido Biosciences is a clinical-stage company that develops precision medicines for severe neurological diseases.
2018
11-50
Watertown, Massachusetts, United States

Investment Funding

Last Funding Stage

Series B

Total Funding Amount

109.M

Last Funding Amount

86.6M

Last Funding Date

15-05-2023

Startup Stage

Early Stage

Lead Investors

Bessemer Venture Partners, Eli Lilly, 5AM Ventures, OUP (Osage University Partners), Abingworth

Revenue

$1M to $10M

People

Founders

Something missing or incorrect on this page? Help us enrich this information